Definitive Contract HHSN268201400009C
- Not listed
- This is a definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Humacyte Global Inc., a for-profit manufacturer, for the "Vascular Interventions/Innovations and Therapeutic Advances (VITA): Bioengineered Grafts for Peripheral Vascular Disease" program. The contract, which has a potential value of $1,570,756.00, is for a base period from November 15, 2013 to November 14, 2014, with a completion...
- This is a federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the Allegheny Singer Research Institute (AHN Research Institute) to conduct a study exploring the feasibility of using combined modalities to test the safety of the CardioMEMS device in patients with pulmonary arterial hypertension (PAH). The contract, valued at $778,004.14, is for the VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA) program and has a definitive...
- This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to The Medical College of Wisconsin, Inc. (MCW), a private medical school and graduate school located in Milwaukee, Wisconsin. The contract, valued at $109,457.00, is for "ESTIMATION OF TREATMENT IN HEMATOLOGIC ONCOLOGY (HO) TRIALS IN THE PRESENCE OF SUBSEQUENT THERAPIES" and has a completion date of March 15, 2021. No set-aside designation was indicated. Through past prime...
- This federal contract award, with an ID of HHSN268201400005C, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the Regents of the University of California, San Francisco (UCSF). The contract is for the "VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): PRO-RESOLVING VASCULAR DEVICES" program, with a base period from November 15, 2013 to November 14, 2014 and a total completion date of November 14, 2016. The contract, which is...
- This is a $100,000.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA) to The Medical College of Wisconsin, Inc. (MCW) for research and development to estimate causal treatment effects in hematologic oncology trials in the presence of multiple subsequent therapies. The contract is part of the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory Science, which seeks proposals across various regulatory science focus areas to modernize the agency's...
- This is a $460,975.01 firm fixed-price delivery order awarded by the National Institutes of Health (NIH) National Cancer Institute to The Medical College of Wisconsin, Inc. (MCW), a private medical school and graduate institution. The contract is part of the NIH's "PREVENT Cancer Program (PREVENT)" and supports the "Preclinical Prevent Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers" major program. No set-aside designation was used. Through past...
- This is a definitive contract awarded by a U.S. government agency to The Medical College of Wisconsin, Inc. (MCW) for STEM CELL TRANSPLANTATION FOR TREATMENT OF AUTO IMMUNE DISEASE. The contract has a ceiling value of $6,382,558.00 and was awarded on March 4, 2005 with an ultimate completion date of August 31, 2012. No small business set-aside was used for this contract. MCW is a private, non-profit medical school and research institution located in Milwaukee, Wisconsin that frequently...
- The Department of Veterans Affairs Veterans Health Administration (VHA) awarded a $94,729.19 fixed-price redetermination contract to The Medical College of Wisconsin, Inc. (MCW) to provide research support services. The contract is part of VHA's Veterans Integrated Service Network 4 program and does not have a small business set-aside. MCW is a private non-profit medical school that has extensive experience collaborating with federal agencies on research initiatives, including vehicle safety...
- The University of Illinois at Chicago, through The Board of Trustees of the University of Illinois, received a $928,761.27 definitive contract award from the National Heart, Lung, and Blood Institute (NHLBI) on November 14, 2016, for a novel drug-based therapy focused on treatment of vascular leakage. The project, titled "Vascular Interventions/Innovations and Therapeutic Advances" (VITA 2), was conducted at the University of Illinois Chicago campus and operated under a cost, no-fee...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $507,383.69 fixed-price redetermination delivery order contract to The Medical College of Wisconsin, Inc. (MCW), a private non-profit university and medical school. The contract provides academic affiliate research support services to the VHA Veterans Integrated Service Network 4 program with a completion date of June 30, 2023. MCW has a history of conducting federal research, including vehicle safety...
This is a $608,546.79 definitive contract awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to the Medical College of Wisconsin, Inc. (MCW), a private medical school, to conduct the "Vascular Interventions/Innovations and Therapeutic Advances (VITA): A Study to Identify Molecules (Similar to RR505) that Targets Dual Specific Phosphatase5 (DUSP5)" program. The contract is a cost-no-fee arrangement with a completion date of November 14, 2016. No set-aside designation was indicated. MCW has previously performed federal contracts and grants related to automotive safety research, veterans health services, and various biomedical and public health initiatives. Concordia University, Inc. and Bio-Rad Laboratories, Inc. Life Science Group are listed as subcontractors supporting the VITA program. The VITA program is focused on vascular interventions and therapeutic advances, aligning with the mission of the National Heart, Lung, and Blood Institute.
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
HHSN268201400009C4S | Concordia University, Inc. | Definitive Contract HHSN268201400009C | $100.0k | 6/7/16 | |
HHSN268201400009C3S | Concordia University, Inc. | Definitive Contract HHSN268201400009C | $100.0k | 3/8/16 | |
HHSN268201400009C2S | Bio-Rad Laboratories, Inc. | Definitive Contract HHSN268201400009C | $30.3k | 11/14/15 | |
HHSN268201400009C1S | Concordia University, Inc. | Definitive Contract HHSN268201400009C | $145.5k | 11/14/14 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Close Out | $0 | 4/17/24 | |
| P00005 | Change Order | ($14k) | 7/20/21 | |
| P00004 | Other Administrative Action | ($28k) | 3/6/20 | |
| P00003 | Other Administrative Action | ($18k) | 6/19/19 | |
| 2 | Exercise an Option | $211.7k | 11/15/15 |